Health Catalyst, Inc. revenue
Health Catalyst, Inc.'s revenue was $311m in fiscal 2025, up 1.5% on the year before. Since fiscal 2017 ($73.1m) it has grown at a compound 19.9% a year. Over the last twelve months it was $292m.
Revenue history
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Technology | $208M | 66.9% | ▲ 6.9% |
| Professional Services | $103M | 33.1% | ▼ 7.9% |
| Line of business | Revenue | YoY |
|---|---|---|
| Technology | $208M | ▲ 6.9% |
| Recurring Technology | $208M | ▲ 6.9% |
| Professional Services | $103M | ▼ 7.9% |
| Onetime Technology | $0 | — |
These categories overlap or exclude eliminations, so shares aren't shown.
From Health Catalyst, Inc.'s 10-K filed March 12, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Health Catalyst, Inc. | $292m | -7.5% | 0.9% |
| Healthstream Inc | $321m | 8.8% | 5.4% |
| Definitive Healthcare Corp. | $233m | -5.0% | -0.8% |
| American Well Corp | $219m | -19.0% | -7.4% |
| Genedx Holdings Corp. | $454m | 25.4% | 24.3% |
| Phreesia, Inc. | $508m | 12.9% | 16.7% |
Compare with peers
- Healthstream Inc revenue
- Definitive Healthcare Corp. revenue
- American Well Corp revenue
- Genedx Holdings Corp. revenue
- Phreesia, Inc. revenue
Head to head: HCAT vs HSTMDH vs HCATAMWL vs HCAT
More: Health Care Technology stocks compared, Health Care sector, rankings of US companies